79 related articles for article (PubMed ID: 10938525)
21. Preparation of low density lipoprotein-9-methoxy-ellipticin complex and its cytotoxic effect against L1210 and P 388 leukemic cells in vitro.
Samadi-Baboli M; Favre G; Blancy E; Soula G
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):233-41. PubMed ID: 2702978
[TBL] [Abstract][Full Text] [Related]
22. Cyclosporin A enhances paclitaxel toxicity against leukemia and respiratory epithelial cancers.
Ross HJ; Canada AL; Slater LM
Clin Cancer Res; 1997 Jan; 3(1):57-62. PubMed ID: 9815538
[TBL] [Abstract][Full Text] [Related]
23. Plasma stability and cytotoxicity of lipophilic daunorubicin derivatives incorporated into low density lipoproteins.
Masquelier M; Tirzitis G; Peterson CO; Pålsson M; Amolins A; Plotniece M; Plotniece A; Makarova N; Vitols SG
Eur J Med Chem; 2000 Apr; 35(4):429-38. PubMed ID: 10858603
[TBL] [Abstract][Full Text] [Related]
24. Low-density lipoprotein for delivery of an acrylophenone antineoplastic molecule into malignant cells.
Lestavel-Delattre S; Martin-Nizard F; Clavey V; Testard P; Favre G; Doualin G; Houssaini HS; Bard JM; Duriez P; Delbart C
Cancer Res; 1992 Jul; 52(13):3629-35. PubMed ID: 1617635
[TBL] [Abstract][Full Text] [Related]
25. A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.
Giordano SH; Booser DJ; Murray JL; Ibrahim NK; Rahman ZU; Valero V; Theriault RL; Rosales MF; Rivera E; Frye D; Ewer M; Ordonez NG; Buzdar AU; Hortobagyi GN
Clin Cancer Res; 2002 Nov; 8(11):3360-8. PubMed ID: 12429622
[TBL] [Abstract][Full Text] [Related]
26. Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: an in vitro and in vivo evaluation study.
Elsadek B; Graeser R; Esser N; Schäfer-Obodozie C; Abu Ajaj K; Unger C; Warnecke A; Saleem T; El-Melegy N; Madkor H; Kratz F
Eur J Cancer; 2010 Dec; 46(18):3434-44. PubMed ID: 20933385
[TBL] [Abstract][Full Text] [Related]
27. [Comparative studies of paclitaxel injection "SAWAI" and Taxol® Injection on pharmacokinetics in dogs and in vitro/vivo antitumor activities].
Takahashi M; Hosoda M; Takahashi H; Todo S
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1699-706. PubMed ID: 20841931
[TBL] [Abstract][Full Text] [Related]
28. Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies.
Rodrigues DG; Maria DA; Fernandes DC; Valduga CJ; Couto RD; Ibañez OC; Maranhão RC
Cancer Chemother Pharmacol; 2005 Jun; 55(6):565-76. PubMed ID: 15726368
[TBL] [Abstract][Full Text] [Related]
29. Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complex.
Vitols S; Söderberg-Reid K; Masquelier M; Sjöström B; Peterson C
Br J Cancer; 1990 Nov; 62(5):724-9. PubMed ID: 2245164
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
Patil Y; Sadhukha T; Ma L; Panyam J
J Control Release; 2009 May; 136(1):21-9. PubMed ID: 19331851
[TBL] [Abstract][Full Text] [Related]
31. Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.
Bradley MO; Webb NL; Anthony FH; Devanesan P; Witman PA; Hemamalini S; Chander MC; Baker SD; He L; Horwitz SB; Swindell CS
Clin Cancer Res; 2001 Oct; 7(10):3229-38. PubMed ID: 11595719
[TBL] [Abstract][Full Text] [Related]
32. Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier.
Mooberry LK; Nair M; Paranjape S; McConathy WJ; Lacko AG
J Drug Target; 2010 Jan; 18(1):53-8. PubMed ID: 19637935
[TBL] [Abstract][Full Text] [Related]
33. Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiation.
Vitols S; Gahrton G; Ost A; Peterson C
Blood; 1984 May; 63(5):1186-93. PubMed ID: 6324928
[TBL] [Abstract][Full Text] [Related]
34. Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study.
Caocci G; Mulas O; Capodanno I; Abruzzese E; Iurlo A; Luciano L; Albano F; Annunziata M; Tiribelli M; Bonifacio M; Galimberti S; Castagnetti F; Sgherza N; Stagno F; Gozzini A; Orlandi EM; Luzi D; Binotto G; Pregno P; Fozza C; Efficace F; Simula MP; Trawinska MM; Cattaneo D; De Gregorio F; Attolico I; Stella R; Scaffidi L; Baratè C; Gugliotta G; Scalzulli E; Elena C; Pirillo F; Foà R; Breccia M; Nasa G
Blood Cancer J; 2020 Jun; 10(6):66. PubMed ID: 32514110
[No Abstract] [Full Text] [Related]
35. Low density lipoprotein for cytotoxic drug targeting: improved activity of elliptinium derivative against B16 melanoma in mice.
Samadi-Baboli M; Favre G; Canal P; Soula G
Br J Cancer; 1993 Aug; 68(2):319-26. PubMed ID: 8347487
[TBL] [Abstract][Full Text] [Related]
36. [The antioxidant system function of the blood in leukemia patients and its alteration during combined therapy].
Baskovich GA; Tkhorzhevskaia ZS; Panina AIu; Gritsaev SV; Kiseleva NN; Makarova IN; Abdulkadyrov KM
Gematol Transfuziol; 1993 Mar; 38(3):13-6. PubMed ID: 8020726
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxic activity of two new lipophilic steroid nitrogen carbamates incorporated into low-density lipoprotein.
Lundberg B
Anticancer Drug Des; 1994 Oct; 9(5):471-6. PubMed ID: 7945729
[TBL] [Abstract][Full Text] [Related]
38. Purine nucleotide content in the leukocytes of leukemia patients.
Carlucci F; Tabucchi A; Consolmagno E; Dispensa E; Galieni P; Pagani R; Pizzichini M; Leoncini R; Marinello E
Adv Exp Med Biol; 1994; 370():237-41. PubMed ID: 7660898
[No Abstract] [Full Text] [Related]
39. [The prognostic role of complement activity in hemoblastoses].
Husieva SA; Klymenko LM; Dolia SM
Lik Sprava; 1993 Jul; (7):82-4. PubMed ID: 8209543
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo studies on plasma-to-blood ratio of paclitaxel in human, rabbit and rat blood fractions.
Liu XR; Wu KC; Huang Y; Sun JB; Ke XY; Wang JC; Lu WL; Zhang X; Zhang Q
Biol Pharm Bull; 2008 Jun; 31(6):1215-20. PubMed ID: 18520057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
